Medscape Conference Coverage, based on selected sessions at the:

American Neurological Association (ANA) 133rd Annual Meeting

September 21 - 24, 2008; Salt Lake City, Utah

This activity is not sanctioned by, nor a part of, the American Neurological Association. Conference news does not receive grant support and is produced independently.

CME on This Topic

Video Highlights

Video Highlights From the ANA 133rd Annual Meeting

Important studies presented at the meeting include reports on neurologic injuries stemming from the conflicts in Iraq and Afghanistan, early vs later treatment of Parkinson's disease, and vitamin D associated with the risk for multiple sclerosis.
Medscape Medical News, October 16, 2008

Conference News

Baroreflex Failure Linked to Radiation for Head and Neck Cancer

Baroreflex failure following chemotherapy is an underrecognized cause of labile blood pressures, resulting in hypertension, orthostatic hypotension, and syncope, researchers warn.
Medscape Medical News, October 3, 2008
Extended-Release Memantine Appears Safe and Effective in Alzheimer's

New trial data suggest that a large 28-mg, once-daily dose may be an option in moderate to severe Alzheimer's disease.
Medscape Medical News, October 2, 2008
New Predictors May Signal Dementia Risk in Early Parkinson's

Much more than a motor illness, Parkinson's disease can have a significant impact on cognition, researchers emphasize.
Medscape Medical News, September 30, 2008
Vitamin D Linked to Genetic and Environmental Risk for MS

New evidence suggests a connection between vitamin D levels and the pathogenesis of multiple sclerosis.
Medscape Medical News, September 26, 2008
Pediatric Patients Have Higher Disease Burden at Time of MS Onset

While the clinical course of disease is often similar between pediatric and adult patients, MRI findings can look different at onset, specialists point out.
Medscape Medical News, September 26, 2008
Early Rasagiline May Have Disease-Modifying Effect in Parkinson's

Early treatment with rasagiline 1 mg per day provided benefits that were not obtained with later initiation. But the 2-mg dose did not meet the primary end point for the trial.
Medscape Medical News, September 24, 2008
War-Related Epilepsy on the Rise in Soldiers and Civilians

Blast injuries arising from the conflicts in Iraq and Afghanistan are having serious neurologic consequences, warn researchers.
Medscape Medical News, September 23, 2008

Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Neurological Association. These materials and the related activity are not sanctioned by the American Neurological Association or the commercial supporter of the conference and do not constitute an official part of that conference.